Drug Name | Pathway ID | Pathway name | P-value | No. of gene members | UniProt AC | Gene name | Detail of Coexpression | |
---|
Ritonavir | hsa00052 | Galactose metabolism | 1.03E-02 | 2 | P06280, O43451 | GLA, MGAM | More | | Ritonavir | hsa00120 | Primary bile acid biosynthesis | 3.72E-02 | 2 | P22680, P22307 | CYP7A1, SCP2 | More | | Ritonavir | hsa00190 | Oxidative phosphorylation | 1.07E-02 | 3 | Q16718, Q13488, O14521 | NDUFA5, TCIRG1, SDHD | More | | Ritonavir | hsa00220 | Arginine biosynthesis | 1.43E-02 | 2 | P05089, P49448 | ARG1, GLUD2 | More | | Ritonavir | hsa00500 | Starch and sucrose metabolism | 6.40E-04 | 3 | O43451, P46976, P06737 | MGAM, GYG1, PYGL | More | | Ritonavir | hsa00520 | Amino sugar and nucleotide sugar metabolism | 2.24E-02 | 3 | Q16222, Q9Y223, P06865 | UAP1, GNE, HEXA | More | | Ritonavir | hsa00533 | Glycosaminoglycan biosynthesis - keratan sulfate | 3.43E-02 | 1 | Q9NY97 | B3GNT2 | More | | Ritonavir | hsa00590 | Arachidonic acid metabolism | 3.85E-02 | 2 | P11712, P09960 | CYP2C9, LTA4H | More | | Ritonavir | hsa00591 | Linoleic acid metabolism | 4.07E-02 | 1 | P11712 | CYP2C9 | More | | Ritonavir | hsa00630 | Glyoxylate and dicarboxylate metabolism | 6.94E-03 | 2 | P40925, P15104 | MDH1, GLUL | More | | Ritonavir | hsa00730 | Thiamine metabolism | 5.86E-04 | 2 | P05186, P24666 | ALPL, ACP1 | More | | Ritonavir | hsa00980 | Metabolism of xenobiotics by cytochrome P450 | 9.14E-03 | 2 | P78417, P11712 | GSTO1, CYP2C9 | More | | Ritonavir | hsa00982 | Drug metabolism - cytochrome P450 | 9.14E-03 | 2 | P11712, P78417 | CYP2C9, GSTO1 | More | | Ritonavir | hsa00983 | Drug metabolism - other enzymes | 2.44E-02 | 2 | P32320, P05164 | CDA, MPO | More | | Ritonavir | hsa01100 | Metabolic pathways | 4.43E-02 | 23 | Q9NR34, P05089, P32320, P22748, P55809, P06280, Q16875, O43286, O43451, P05186, P24666, Q9HCC0, P33121, P57054, Q9UNP4, Q9BX95, P32321, Q9BPW9, O75911, Q9UHY7, P43490, P46976, P06737 | MAN1C1, ARG1, CDA, CA4, OXCT1, GLA, PFKFB3, B4GALT5, MGAM, ALPL, ACP1, MCCC2, ACSL1, PIGP, ST3GAL5, SGPP1, DCTD, DHRS9, DHRS3, ENOPH1, PBEF1, GYG1, PYGL | More | | Ritonavir | hsa01524 | Platinum drug resistance | 4.67E-02 | 4 | Q13489, P98170, P78417, P43246 | BIRC3, BIRC4, GSTO1, MSH2 | More | | Ritonavir | hsa03013 | RNA transport | 2.99E-02 | 4 | P38919, P37198, P35658, P55884 | EIF4A3, NUP62, NUP214, EIF3B | More | | Ritonavir | hsa03040 | Spliceosome | 3.59E-04 | 11 | Q14562, O43143, P08579, P26368, O75940, O75494, Q13595, Q07955, Q01130, P84103, Q13243 | DHX8, DHX15, SNRPB2, U2AF2, SMNDC1, FUSIP1, TRA2A, SFRS1, SFRS2, SFRS3, SFRS5 | More | | Ritonavir | hsa03050 | Proteasome | 4.83E-02 | 1 | P55036 | PSMD4 | More | | Ritonavir | hsa04014 | Ras signaling pathway | 1.70E-02 | 7 | P20827, Q9NRA1, P49767, P17252, P0DP23, P62873, P19174 | EFNA1, PDGFC, VEGFC, PRKCA, CALM1, GNB1, PLCG1 | More | | Ritonavir | hsa04015 | Rap1 signaling pathway | 4.58E-02 | 6 | P20827, Q9NRA1, P49767, P0DP23, P17252, P19174 | EFNA1, PDGFC, VEGFC, CALM1, PRKCA, PLCG1 | More | | Ritonavir | hsa04020 | Calcium signaling pathway | 2.01E-02 | 6 | P17252, P19174, P0DP23, P20020, Q9NRA1, P49767 | PRKCA, PLCG1, CALM1, ATP2B1, PDGFC, VEGFC | More | | Ritonavir | hsa04062 | Chemokine signaling pathway | 3.81E-02 | 6 | P07948, P62873, P63218, P50151, P43250, Q13009 | LYN, GNB1, GNG5, GNG10, GRK6, TIAM1 | More | | Ritonavir | hsa04064 | NF-kappa B signaling pathway | 2.99E-02 | 7 | O00463, P14778, Q13077, Q16548, Q8WV28, P24522, P09341 | TRAF5, IL1R1, TRAF1, BCL2A1, BLNK, GADD45A, CXCL1 | More | | Ritonavir | hsa04070 | Phosphatidylinositol signaling system | 4.40E-02 | 4 | P19174, P0DP23, P23743, P17252 | PLCG1, CALM1, DGKA, PRKCA | More | | Ritonavir | hsa04071 | Sphingolipid signaling pathway | 1.94E-02 | 3 | Q9H228, P01375, Q9UQC2 | EDG8, TNF, GAB2 | More | | Ritonavir | hsa04145 | Phagosome | 4.68E-02 | 5 | Q15080, P14598, Q13509, P68371, Q13488 | NCF4, NCF1, TUBB3, TUBB2C, TCIRG1 | More | | Ritonavir | hsa04210 | Apoptosis | 3.58E-02 | 4 | O76075, P01375, Q9NR28, Q16548 | DFFB, TNF, DIABLO, BCL2A1 | More | | Ritonavir | hsa04213 | Longevity regulating pathway - multiple species | 2.85E-02 | 2 | Q9Y4H2, Q13547 | IRS2, HDAC1 | More | | Ritonavir | hsa04215 | Apoptosis - multiple species | 1.56E-02 | 2 | Q13489, P10415 | BIRC3, BCL2 | More | | Ritonavir | hsa04217 | Necroptosis | 5.72E-04 | 11 | P01568, Q13489, P98170, P42224, P08238, P15104, Q6FI13, Q93077, O43633, P21796, Q08752 | IFNA21, BIRC3, BIRC4, STAT1, HSP90AB1, GLUL, H2AC18; H2AC19, HIST1H2AC, CHMP2A, VDAC1, PPID | More | | Ritonavir | hsa04330 | Notch signaling pathway | 2.77E-02 | 2 | Q92542, P49768 | NCSTN, PSEN1 | More | | Ritonavir | hsa04340 | Hedgehog signaling pathway | 3.32E-02 | 2 | P49841, P22694 | GSK3B, PRKACB | More | | Ritonavir | hsa04350 | TGF-beta signaling pathway | 4.88E-02 | 1 | P37173 | TGFBR2 | More | | Ritonavir | hsa04360 | Axon guidance | 2.29E-02 | 5 | P16333, P20827, O95631, P17252, P19174 | NCK1, EFNA1, NTN1, PRKCA, PLCG1 | More | | Ritonavir | hsa04371 | Apelin signaling pathway | 3.23E-04 | 7 | P62873, P63218, P50151, Q13485, P84022, Q16566, P0DP23 | GNB1, GNG5, GNG10, SMAD4, SMAD3, CAMK4, CALM1 | More | | Ritonavir | hsa04390 | Hippo signaling pathway | 2.08E-02 | 3 | P84022, Q13485, Q13489 | SMAD3, SMAD4, BIRC3 | More | | Ritonavir | hsa04392 | Hippo signaling pathway - multiple species | 3.01E-02 | 1 | Q6V0I7 | FAT4 | More | | Ritonavir | hsa04530 | Tight junction | 3.29E-02 | 3 | P16989, P56750, Q14247 | CSDA, CLDN17, CTTN | More | | Ritonavir | hsa04540 | Gap junction | 1.67E-02 | 4 | P17252, Q13509, P68371, Q9NRA1 | PRKCA, TUBB3, TUBB2C, PDGFC | More | | Ritonavir | hsa04610 | Complement and coagulation cascades | 3.16E-03 | 2 | P00734, P0C0L4 | F2, C4A | More | | Ritonavir | hsa04612 | Antigen processing and presentation | 8.21E-03 | 5 | P26715, P26717, Q07444, Q13241, P01732 | KLRC1, KLRC2, KLRC3, KLRD1, CD8A | More | | Ritonavir | hsa04613 | Neutrophil extracellular trap formation | 1.02E-04 | 8 | P11215, Q13547, Q93077, P58876, P62807, Q16778, O60814, P68431 | ITGAM, HDAC1, HIST1H2AC, H2BC5, HIST1H2BC, HIST2H2BE, H2BC12, H3C1; H3C2; H3C3; H3C4; H3C6; H3C7; H3C8; H3C10; H3C11; H3C12 | More | | Ritonavir | hsa04614 | Renin-angiotensin system | 1.52E-02 | 1 | P50052 | AGTR2 | More | | Ritonavir | hsa04623 | Cytosolic DNA-sensing pathway | 3.29E-02 | 2 | P01568, P25963 | IFNA21, NFKBIA | More | | Ritonavir | hsa04650 | Natural killer cell mediated cytotoxicity | 8.48E-05 | 8 | P06239, P20963, Q13241, P26718, O14931, P26717, Q07444, P26715 | LCK, CD247, KLRD1, KLRK1, NCR3, KLRC2, KLRC3, KLRC1 | More | | Ritonavir | hsa04657 | IL-17 signaling pathway | 4.49E-04 | 11 | P25963, P08238, O00463, Q07955, Q16539, P49841, P09341, P14780, P04141, P01375, P06702 | NFKBIA, HSP90AB1, TRAF5, SFRS1, MAPK14, GSK3B, CXCL1, MMP9, CSF2, TNF, S100A9 | More | | Ritonavir | hsa04658 | Th1 and Th2 cell differentiation | 7.09E-05 | 7 | Q04759, P20963, P09693, P06239, P23771, Q9UL17, Q13761 | PRKCQ, CD247, CD3G, LCK, GATA3, TBX21, RUNX3 | More | | Ritonavir | hsa04659 | Th17 cell differentiation | 2.18E-04 | 9 | P25963, Q04759, P06239, Q9UL17, P23771, P84022, Q13485, P09693, P20963 | NFKBIA, PRKCQ, LCK, TBX21, GATA3, SMAD3, SMAD4, CD3G, CD247 | More | | Ritonavir | hsa04660 | T cell receptor signaling pathway | 1.84E-04 | 13 | P04141, P25963, Q04759, P10747, O95267, Q08881, P19174, P16333, P20963, P09693, P01732, P06239, P29350 | CSF2, NFKBIA, PRKCQ, CD28, RASGRP1, ITK, PLCG1, NCK1, CD247, CD3G, CD8A, LCK, PTPN6 | More | | Ritonavir | hsa04710 | Circadian rhythm | 1.67E-02 | 2 | Q16526, Q9Y478 | CRY1, PRKAB1 | More | | Ritonavir | hsa04713 | Circadian entrainment | 2.13E-04 | 7 | O15399, P0DP23, P17252, P62873, P63218, P50151, O15055 | GRIN2D, CALM1, PRKCA, GNB1, GNG5, GNG10, PER2 | More | | Ritonavir | hsa04720 | Long-term potentiation | 2.33E-02 | 3 | Q16566, P0DP23, O15399 | CAMK4, CALM1, GRIN2D | More | | Ritonavir | hsa04724 | Glutamatergic synapse | 1.11E-03 | 5 | O15399, P62873, P63218, P50151, P15104 | GRIN2D, GNB1, GNG5, GNG10, GLUL | More | | Ritonavir | hsa04725 | Cholinergic synapse | 9.51E-03 | 4 | P62873, P63218, P50151, Q16566 | GNB1, GNG5, GNG10, CAMK4 | More | | Ritonavir | hsa04726 | Serotonergic synapse | 2.38E-02 | 4 | P62873, P63218, P50151, P09917 | GNB1, GNG5, GNG10, ALOX5 | More | | Ritonavir | hsa04727 | GABAergic synapse | 2.45E-03 | 4 | P62873, P63218, P50151, P15104 | GNB1, GNG5, GNG10, GLUL | More | | Ritonavir | hsa04744 | Phototransduction | 8.39E-05 | 2 | P62873, P0DP23 | GNB1, CALM1 | More | | Ritonavir | hsa04910 | Insulin signaling pathway | 2.35E-02 | 3 | P22694, P06737, P49841 | PRKACB, PYGL, GSK3B | More | | Ritonavir | hsa04919 | Thyroid hormone signaling pathway | 7.11E-03 | 4 | P49841, P22694, O60244, Q9NVC6 | GSK3B, PRKACB, MED14, MED17 | More | | Ritonavir | hsa04920 | Adipocytokine signaling pathway | 4.31E-02 | 2 | Q9Y478, Q96RR4 | PRKAB1, CAMKK2 | More | | Ritonavir | hsa04931 | Insulin resistance | 1.94E-02 | 3 | P01375, P49841, P06737 | TNF, GSK3B, PYGL | More | | Ritonavir | hsa04933 | AGE-RAGE signaling pathway in diabetic complications | 8.48E-04 | 8 | P84022, Q13485, P42224, P10415, Q12778, P49767, P17252, P19174 | SMAD3, SMAD4, STAT1, BCL2, FOXO1, VEGFC, PRKCA, PLCG1 | More | | Ritonavir | hsa04975 | Fat digestion and absorption | 3.43E-02 | 1 | O14494 | PLPP1 | More | | Ritonavir | hsa04976 | Bile secretion | 2.44E-02 | 2 | P22694, P08183 | PRKACB, ABCB1 | More | | Ritonavir | hsa05012 | Parkinson disease | 3.12E-02 | 6 | Q16718, O14521, P19174, P0DP23, Q13509, P68371 | NDUFA5, SDHD, PLCG1, CALM1, TUBB3, TUBB2C | More | | Ritonavir | hsa05022 | Pathways of neurodegeneration - multiple diseases | 1.87E-02 | 11 | Q13509, P68371, Q16718, O14521, Q06055, Q13561, P19174, P17252, Q08752, O15020, P0DP23 | TUBB3, TUBB2C, NDUFA5, SDHD, ATP5G2, DCTN2, PLCG1, PRKCA, PPID, SPTBN2, CALM1 | More | | Ritonavir | hsa05032 | Morphine addiction | 1.34E-02 | 4 | P62873, P63218, P50151, P43250 | GNB1, GNG5, GNG10, GRK6 | More | | Ritonavir | hsa05034 | Alcoholism | 5.46E-07 | 14 | O15399, Q16566, Q13547, P0DP23, P62873, P63218, P50151, Q93077, P58876, P62807, Q93079, Q16778, O60814, P68431 | GRIN2D, CAMK4, HDAC1, CALM1, GNB1, GNG5, GNG10, HIST1H2AC, H2BC5, HIST1H2BC, H2BC9, HIST2H2BE, H2BC12, H3C1; H3C2; H3C3; H3C4; H3C6; H3C7; H3C8; H3C10; H3C11; H3C12 | More | | Ritonavir | hsa05110 | Vibrio cholerae infection | 1.98E-02 | 3 | Q13488, P17252, P19174 | TCIRG1, PRKCA, PLCG1 | More | | Ritonavir | hsa05120 | Epithelial cell signaling in Helicobacter pylori infection | 2.45E-02 | 4 | Q16539, P09341, P25024, P25025 | MAPK14, CXCL1, CXCR1, CXCR2 | More | | Ritonavir | hsa05132 | Salmonella infection | 1.41E-03 | 11 | P25963, P08238, Q13489, P10415, P04406, O75369, Q9BQS8, Q13561, Q13509, P68371, P49754 | NFKBIA, HSP90AB1, BIRC3, BCL2, GAPDH, FLNB, FYCO1, DCTN2, TUBB3, TUBB2C, VPS41 | More | | Ritonavir | hsa05133 | Pertussis | 2.24E-02 | 2 | P0DP23, P0C0L4 | CALM1, C4A | More | | Ritonavir | hsa05140 | Leishmaniasis | 1.26E-03 | 10 | O75015, P14598, P42224, P13765, O60603, P25963, P29350, P49006, Q16539, Q15080 | FCGR3B, NCF1, STAT1, HLA-DOB, TLR2, NFKBIA, PTPN6, MARCKSL1, MAPK14, NCF4 | More | | Ritonavir | hsa05143 | African trypanosomiasis | 4.81E-02 | 2 | P69905, P68871 | HBA2, HBB | More | | Ritonavir | hsa05145 | Toxoplasmosis | 2.78E-02 | 3 | P25963, P10415, Q13489 | NFKBIA, BCL2, BIRC3 | More | | Ritonavir | hsa05146 | Amoebiasis | 3.65E-03 | 7 | P09341, P14778, P27930, O60603, P05089, P12814, P08311 | CXCL1, IL1R1, IL1R2, TLR2, ARG1, ACTN1, CTSG | More | | Ritonavir | hsa05161 | Hepatitis B | 8.49E-03 | 4 | P25963, Q13485, P10415, P84022 | NFKBIA, SMAD4, BCL2, SMAD3 | More | | Ritonavir | hsa05163 | Human cytomegalovirus infection | 2.30E-03 | 13 | P62873, P63218, P50151, Q14643, P0DP23, P49841, P14778, P25025, Q16539, P04637, O00463, P30101, P01568 | GNB1, GNG5, GNG10, ITPR1, CALM1, GSK3B, IL1R1, CXCR2, MAPK14, TP53, TRAF5, PDIA3, IFNA21 | More | | Ritonavir | hsa05167 | Kaposi sarcoma-associated herpesvirus infection | 3.59E-04 | 11 | P01568, P42224, P25963, P40189, P62873, P63218, P50151, P19174, P07948, P04141, P0DP23 | IFNA21, STAT1, NFKBIA, IL6ST, GNB1, GNG5, GNG10, PLCG1, LYN, CSF2, CALM1 | More | | Ritonavir | hsa05168 | Herpes simplex virus 1 infection | 6.56E-04 | 16 | P25963, P01568, Q9GZY0, P42224, Q07955, Q01130, P84103, Q13243, Q13489, P30101, Q13398, Q03923, P52738, O75820, Q9NZL3, Q9UDV6 | NFKBIA, IFNA21, NXF2; NXF2B, STAT1, SFRS1, SFRS2, SFRS3, SFRS5, BIRC3, PDIA3, ZNF211, ZNF85, ZNF140, ZNF189, ZNF224, ZNF212 | More | | Ritonavir | hsa05170 | Human immunodeficiency virus 1 infection | 1.83E-02 | 7 | P62873, P63218, P50151, P0DP23, P30101, P01568, P23528 | GNB1, GNG5, GNG10, CALM1, PDIA3, IFNA21, CFL1 | More | | Ritonavir | hsa05171 | Coronavirus disease - COVID-19 | 1.36E-02 | 7 | P25963, P42224, P01568, P40189, P04141, P19174, P17252 | NFKBIA, STAT1, IFNA21, IL6ST, CSF2, PLCG1, PRKCA | More | | Ritonavir | hsa05200 | Pathways in cancer | 4.38E-05 | 23 | Q13751, P08238, P42224, P25963, P19174, P17252, P43246, P84022, Q13485, P14923, Q13489, P98170, P49767, Q12778, P62873, P63218, P50151, P78417, O75293, P0DP23, P01568, P40189, P01042 | LAMB3, HSP90AB1, STAT1, NFKBIA, PLCG1, PRKCA, MSH2, SMAD3, SMAD4, JUP, BIRC3, BIRC4, VEGFC, FOXO1, GNB1, GNG5, GNG10, GSTO1, GADD45B, CALM1, IFNA21, IL6ST, KNG1 | More | Genes in community(ComG) | Gene name of ComG | Protein name of ComG | Co-expressed genes in pathway (PathG) | Gene name of PathG | Protein name of PathG | Coexpression |
---|
Q96KQ7 | EHMT2 | Histone-lysine N-methyltransferase EHMT2 | Q13751 | LAMB3 | Laminin subunit beta-3 | 0.868 | Q13370 | PDE3B | cGMP-inhibited 3',5'-cyclic phosphodiesterase B | P08238 | HSP90AB1 | Heat shock protein HSP 90-beta | -0.826 | Q96KQ7 | EHMT2 | Histone-lysine N-methyltransferase EHMT2 | P08238 | HSP90AB1 | Heat shock protein HSP 90-beta | -0.724 | Q13370 | PDE3B | cGMP-inhibited 3',5'-cyclic phosphodiesterase B | P42224 | STAT1 | Signal transducer and activator of transcription 1-alpha/beta | -0.912 | Q13370 | PDE3B | cGMP-inhibited 3',5'-cyclic phosphodiesterase B | P25963 | NFKBIA | NF-kappa-B inhibitor alpha | -0.739 | Q13370 | PDE3B | cGMP-inhibited 3',5'-cyclic phosphodiesterase B | P19174 | PLCG1 | 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1 | -0.739 | Q13370 | PDE3B | cGMP-inhibited 3',5'-cyclic phosphodiesterase B | P17252 | PRKCA | Protein kinase C alpha type | 0.832 | Q13370 | PDE3B | cGMP-inhibited 3',5'-cyclic phosphodiesterase B | P43246 | MSH2 | DNA mismatch repair protein Msh2 | -0.768 | Q96KQ7 | EHMT2 | Histone-lysine N-methyltransferase EHMT2 | P43246 | MSH2 | DNA mismatch repair protein Msh2 | -0.742 | Q96KQ7 | EHMT2 | Histone-lysine N-methyltransferase EHMT2 | P84022 | SMAD3 | Mothers against decapentaplegic homolog 3 | 0.847 | Q96KQ7 | EHMT2 | Histone-lysine N-methyltransferase EHMT2 | Q13485 | SMAD4 | Mothers against decapentaplegic homolog 4 | -0.899 | Q13370 | PDE3B | cGMP-inhibited 3',5'-cyclic phosphodiesterase B | P14923 | JUP | Junction plakoglobin | 0.735 | Q96KQ7 | EHMT2 | Histone-lysine N-methyltransferase EHMT2 | Q13489 | BIRC3 | Baculoviral IAP repeat-containing protein 3 | 0.715 | Q96KQ7 | EHMT2 | Histone-lysine N-methyltransferase EHMT2 | P98170 | BIRC4 | E3 ubiquitin-protein ligase XIAP | 0.716 | Q13370 | PDE3B | cGMP-inhibited 3',5'-cyclic phosphodiesterase B | P49767 | VEGFC | Vascular endothelial growth factor C | 0.761 | Q13370 | PDE3B | cGMP-inhibited 3',5'-cyclic phosphodiesterase B | Q12778 | FOXO1 | Forkhead box protein O1 | 0.753 | Q13370 | PDE3B | cGMP-inhibited 3',5'-cyclic phosphodiesterase B | P62873 | GNB1 | Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-1 | -0.833 | Q96KQ7 | EHMT2 | Histone-lysine N-methyltransferase EHMT2 | P62873 | GNB1 | Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-1 | -0.709 | Q96KQ7 | EHMT2 | Histone-lysine N-methyltransferase EHMT2 | P63218 | GNG5 | Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-5 | 0.759 | Q96KQ7 | EHMT2 | Histone-lysine N-methyltransferase EHMT2 | P50151 | GNG10 | Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-10 | 0.744 | Q96KQ7 | EHMT2 | Histone-lysine N-methyltransferase EHMT2 | P78417 | GSTO1 | Glutathione S-transferase omega-1 | 0.754 | Q13370 | PDE3B | cGMP-inhibited 3',5'-cyclic phosphodiesterase B | O75293 | GADD45B | Growth arrest and DNA damage-inducible protein GADD45 beta | 0.713 | Q96KQ7 | EHMT2 | Histone-lysine N-methyltransferase EHMT2 | O75293 | GADD45B | Growth arrest and DNA damage-inducible protein GADD45 beta | 0.708 | Q13370 | PDE3B | cGMP-inhibited 3',5'-cyclic phosphodiesterase B | P0DP23 | CALM1 | Calmodulin-1 | -0.761 | Q96KQ7 | EHMT2 | Histone-lysine N-methyltransferase EHMT2 | P0DP23 | CALM1 | Calmodulin-1 | -0.724 | Q13370 | PDE3B | cGMP-inhibited 3',5'-cyclic phosphodiesterase B | P01568 | IFNA21 | Interferon alpha-21 | 0.729 | Q96KQ7 | EHMT2 | Histone-lysine N-methyltransferase EHMT2 | P01568 | IFNA21 | Interferon alpha-21 | 0.703 | Q13370 | PDE3B | cGMP-inhibited 3',5'-cyclic phosphodiesterase B | P40189 | IL6ST | Interleukin-6 receptor subunit beta | -0.746 | Q96KQ7 | EHMT2 | Histone-lysine N-methyltransferase EHMT2 | P01042 | KNG1 | Kininogen-1 | 0.708 |
| Ritonavir | hsa05202 | Transcriptional misregulation in cancer | 1.24E-02 | 4 | P27930, P11215, Q13547, P12980 | IL1R2, ITGAM, HDAC1, LYL1 | More | | Ritonavir | hsa05203 | Viral carcinogenesis | 1.22E-03 | 6 | Q13547, Q15283, P58876, P62807, Q16778, O60814 | HDAC1, RASA2, H2BC5, HIST1H2BC, HIST2H2BE, H2BC12 | More | | Ritonavir | hsa05204 | Chemical carcinogenesis | 1.48E-02 | 2 | P78417, P11712 | GSTO1, CYP2C9 | More | | Ritonavir | hsa05210 | Colorectal cancer | 2.90E-03 | 5 | P84022, Q13485, P43246, P10415, O75293 | SMAD3, SMAD4, MSH2, BCL2, GADD45B | More | | Ritonavir | hsa05212 | Pancreatic cancer | 5.72E-04 | 4 | P37173, P84022, Q13485, O75293 | TGFBR2, SMAD3, SMAD4, GADD45B | More | | Ritonavir | hsa05214 | Glioma | 8.71E-04 | 5 | P0DP23, Q16566, P17252, P19174, O75293 | CALM1, CAMK4, PRKCA, PLCG1, GADD45B | More | | Ritonavir | hsa05219 | Bladder cancer | 4.07E-02 | 2 | P14780, P04637 | MMP9, TP53 | More | | Ritonavir | hsa05220 | Chronic myeloid leukemia | 1.25E-02 | 3 | Q13485, P25963, P84022 | SMAD4, NFKBIA, SMAD3 | More | | Ritonavir | hsa05222 | Small cell lung cancer | 2.00E-03 | 6 | Q13751, Q13489, P98170, P10415, P25963, O75293 | LAMB3, BIRC3, BIRC4, BCL2, NFKBIA, GADD45B | More | | Ritonavir | hsa05224 | Breast cancer | 4.75E-02 | 4 | P49841, Q92837, P04637, P24522 | GSK3B, FRAT1, TP53, GADD45A | More | | Ritonavir | hsa05226 | Gastric cancer | 2.78E-02 | 3 | P84022, Q13485, P10415 | SMAD3, SMAD4, BCL2 | More | | Ritonavir | hsa05231 | Choline metabolism in cancer | 2.25E-03 | 5 | Q9NRA1, Q9Y259, P19174, P23743, P17252 | PDGFC, CHKB, PLCG1, DGKA, PRKCA | More | | Ritonavir | hsa05235 | PD-L1 expression and PD-1 checkpoint pathway in cancer | 8.34E-05 | 13 | P25963, O95267, P19174, P20963, P09693, P06239, P29350, P42224, O60603, P10747, Q04759, Q16539, P01730 | NFKBIA, RASGRP1, PLCG1, CD247, CD3G, LCK, PTPN6, STAT1, TLR2, CD28, PRKCQ, MAPK14, CD4 | More | | Ritonavir | hsa05322 | Systemic lupus erythematosus | 6.31E-07 | 9 | P08311, P09871, Q93077, P58876, P62807, Q16778, O60814, P68431, P12814 | CTSG, C1S, HIST1H2AC, H2BC5, HIST1H2BC, HIST2H2BE, H2BC12, H3C1; H3C2; H3C3; H3C4; H3C6; H3C7; H3C8; H3C10; H3C11; H3C12, ACTN1 | More | | Ritonavir | hsa05415 | Diabetic cardiomyopathy | 1.20E-02 | 6 | P17252, P14598, Q15080, Q16718, O14521, P04406 | PRKCA, NCF1, NCF4, NDUFA5, SDHD, GAPDH | More | | Ritonavir | hsa05418 | Fluid shear stress and atherosclerosis | 2.62E-02 | 6 | Q16539, P10599, P14780, P04637, P14778, P27930 | MAPK14, TXN, MMP9, TP53, IL1R1, IL1R2 | More | | |